Related references
Note: Only part of the references are listed.Lipid droplets induced by secreted phospholipase A(2) and unsaturated fatty acids protect breast cancer cells from nutrient and lipotoxic stress
Eva Jarc et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2018)
Single plasmid systems for inducible dual protein expression and for CRISPR-Cas9/CRISPRi gene regulation in lactic acid bacterium Lactococcus lactis
Ales Berlec et al.
SCIENTIFIC REPORTS (2018)
A review on Lactococcus lactis: from food to factory
Adelene Ai-Lian Song et al.
MICROBIAL CELL FACTORIES (2017)
Pathomechanisms of Oxidative Stress in Inflammatory Bowel Disease and Potential Antioxidant Therapies
Tian Tian et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2017)
Stable gastric pentadecapeptide BPC 157 in the treatment of colitis and ischemia and reperfusion in rats: New insights
Antonija Duzel et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Celecoxib-induced gastrointestinal, liver and brain lesions in rats, counteraction by BPC 157 or L-arginine, aggravation by L-NAME
Domagoj Drmic et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Antioxidant Properties of Probiotic Bacteria
Yang Wang et al.
NUTRIENTS (2017)
Use of Wild Type or Recombinant Lactic Acid Bacteria as an Alternative Treatment for Gastrointestinal Inflammatory Diseases: A Focus on Inflammatory Bowel Diseases and Mucositis
Rodrigo D. De Oliveira Carvalho et al.
FRONTIERS IN MICROBIOLOGY (2017)
Cyclophosphamide induced stomach and duodenal lesions as a NO-system disturbance in rats: L-NAME, L-arginine, stable gastric pentadecapeptide BPC 157
Kresimir Luetic et al.
INFLAMMOPHARMACOLOGY (2017)
Evasin-displaying lactic acid bacteria bind different chemokines and neutralize CXCL8 production in Caco-2 cells
Katja Skrlec et al.
MICROBIAL BIOTECHNOLOGY (2017)
Lactic Acid Bacteria with Concomitant IL-17, IL-23 and TNFα- Binding Ability for the Treatment of Inflammatory Bowel Disease
Stasa Kosler et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2017)
Designer probiotics for the prevention and treatment of human diseases
Koon Jiew Chua et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2017)
Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications
Predrag Sikiric et al.
CURRENT NEUROPHARMACOLOGY (2016)
Display of recombinant proteins at the surface of lactic acid bacteria: strategies and applications
C. Michon et al.
MICROBIAL CELL FACTORIES (2016)
Improvement of LysM-Mediated Surface Display of Designed Ankyrin Repeat Proteins (DARPins) in Recombinant and Nonrecombinant Strains of Lactococcus lactis and Lactobacillus Species
Petra Zadravec et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2015)
Epidemiology and risk factors for IBD
Ashwin N. Ananthakrishnan
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2015)
Body protective compound-157 enhances alkali-burn wound healing in vivo and promotes proliferation, migration, and angiogenesis in vitro
Tonglie Huang et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2015)
Production, secretion and purification of a correctly folded staphylococcal antigen in Lactococcus lactis
Frederic Samazan et al.
MICROBIAL CELL FACTORIES (2015)
Reactive Oxygen Species in Inflammation and Tissue Injury
Manish Mittal et al.
ANTIOXIDANTS & REDOX SIGNALING (2014)
Exploiting the peptidoglycan-binding motif, LysM, for medical and industrial applications
Ganesh Ram R. Visweswaran et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2014)
Engineering BmpA as a carrier for surface display of IgG-binding domain on Lactococcus lactis
Petra Zadravec et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2014)
Systematic review of randomized controlled trials of probiotics, prebiotics, and synbiotics in inflammatory bowel disease
Yezaz A. Ghouri et al.
CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY (2014)
Antioxidant properties of potentially probiotic bacteria: in vitro and in vivo activities
Alberto Amaretti et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2013)
ROS inhibitor N-acetyl-L-cysteine antagonizes the activity of proteasome inhibitors
Marianna Halasi et al.
BIOCHEMICAL JOURNAL (2013)
Toxicity by NSAIDs. Counteraction by Stable Gastric Pentadecapeptide BPC 157
Predrag Sikiric et al.
CURRENT PHARMACEUTICAL DESIGN (2013)
Focus on Ulcerative Colitis: Stable Gastric Pentadecapeptide BPC 157
P. Sikiric et al.
CURRENT MEDICINAL CHEMISTRY (2012)
Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review
Natalie A. Molodecky et al.
GASTROENTEROLOGY (2012)
Lactic acid bacteria: a promising alternative for recombinant protein production
Elena Garcia-Fruitos
MICROBIAL CELL FACTORIES (2012)
Lactic acid bacteria as oral delivery systems for biomolecules
A. Berlec et al.
PHARMAZIE (2012)
Identification of Candidate Carrier Proteins for Surface Display on Lactococcus lactis by Theoretical and Experimental Analyses of the Surface Proteome
Ales Berlec et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2011)
Nisin-Inducible Secretion of a Biologically Active Single-Chain Insulin Analog by Lactococcus lactis NZ9000
Daphne T. W. Ng et al.
BIOTECHNOLOGY AND BIOENGINEERING (2011)
The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration
Chung-Hsun Chang et al.
JOURNAL OF APPLIED PHYSIOLOGY (2011)
Lactococcus lactis as a live vector: Heterologous protein production and DNA delivery systems
Daniela Santos Pontes et al.
PROTEIN EXPRESSION AND PURIFICATION (2011)
Current and emerging drugs for the treatment of inflammatory bowel disease
John K. Triantafillidis et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2011)
Engineered Lactic Acid Bacterium Lactococcus lactis Capable of Binding Antibodies and Tumor Necrosis Factor Alpha
Matjaz Ravnikar et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2010)
Intragastric administration of a superoxide dismutase-producing recombinant Lactobacillus casei BL23 strain attenuates DSS colitis in mice
Laurie Watterlot et al.
INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY (2010)
Pentadecapeptide BPC 157 (PL 14736) Improves Ligament Healing in the Rat
Tomislav Cerovecki et al.
JOURNAL OF ORTHOPAEDIC RESEARCH (2010)
Probiotics and the gut microbiota in intestinal health and disease
Melanie G. Gareau et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2010)
Current Directions in IBD Therapy: What Goals Are Feasible With Biological Modifiers?
William J. Sandborn
GASTROENTEROLOGY (2008)
Pentadecapeptide BPC 157, in clinical trials as a therapy for inflammatory bowel disease (PL14736), is effective in the healing of colocutaneous fistulas in rats: Role of the nitric oxide-system
Robert Klicek et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2008)
Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria
Jerry M. Wells et al.
NATURE REVIEWS MICROBIOLOGY (2008)
Lactococcus lactis, an efficient cell factory for recombinant protein production and secretion
E. Morello et al.
JOURNAL OF MOLECULAR MICROBIOLOGY AND BIOTECHNOLOGY (2008)
Stable gastric pentadecapeptide BPC 157 in trials for inflammatory bowel disease (PL-10, PLD-116, PL14736, pliva, croatia) heals ileoileal anastomosis in the rat
Tihomir Vuksic et al.
SURGERY TODAY (2007)
10 years of the nisin-controlled gene expression system (NICE) in Lactococcus lactis
I Mierau et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2005)
Protein secretion in Lactococcus lactis:: an efficient way to increase the overall heterologous protein production -: art. no. 2
Y Le Loir et al.
MICROBIAL CELL FACTORIES (2005)
Receptor binding domain of Escherichia coli F18 fimbrial adhesin FedF can be both efficiently secreted and surface displayed in a functional form in Lactococcus lactis
A Lindholm et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2004)
Cell wall attachment of a widely distributed peptidoglycan binding domain is hindered by cell wall constituents
A Steen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Oxidative stress and antioxidant capacity in patients with inflammatory bowel disease
A Tüzün et al.
CLINICAL BIOCHEMISTRY (2002)
Lactobacillus bulgaricus proteinase expressed in Lactococcus lactis is a powerful carrier for cell wall-associated and secreted bovine β-lactoglobulin fusion proteins
E Bernasconi et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2002)
Signal peptide and propeptide optimization for heterologous protein secretion in Lactococcus lactis
Y Le Loir et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2001)
Design of a protein-targeting system for lactic acid bacteria
Y Dieye et al.
JOURNAL OF BACTERIOLOGY (2001)
Induction of mucosal immune response after intranasal or oral inoculation of mice with Lactococcus lactis producing bovine beta-lactoglobulin
JM Chatel et al.
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY (2001)
Treatment of murine colitis by Lactococcus lactis secreting interleukin-10
L Steidler et al.
SCIENCE (2000)
Share Paper
